Based on this evidence it is also tempting to speculate that p110γ inhibition may have a more generic role in modulation of cancer cell metabolism beyond the context of obesity and insulin resistant conditions. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.